Terms: = Thyroid cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM
52 results:
1. GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas.
Lennartz M; Benjamin Dünnebier N; Höflmayer D; Dwertmann Rico S; Kind S; Reiswich V; Viehweger F; Lutz F; Fraune C; Gorbokon N; Luebke AM; Hube-Magg C; Büscheck F; Menz A; Uhlig R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Steurer S; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C
Am J Surg Pathol; 2024 Apr; 48(4):377-386. PubMed ID: 38271200
[TBL] [Abstract] [Full Text] [Related]
2. Isthmusectomy for papillarythyroid carcinoma in the isthmus: The less the better.
Dan J; Tan J; Guo Y; Xu Y; Chen J; Huang J
Asian J Surg; 2024 Jan; 47(1):367-372. PubMed ID: 37714784
[TBL] [Abstract] [Full Text] [Related]
3. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid.
Lennartz M; Csomós H; Chirico V; Weidemann S; Gorbokon N; Menz A; Büscheck F; Hube-Magg C; Höflmayer D; Bernreuther C; Blessin NC; Lebok P; Sauter G; Steurer S; Burandt E; Dum D; Krech T; Simon R; Minner S; Jacobsen F; Clauditz TS; Luebke AM; Siraj AK; Al-Dayel F; Al-Kuraya KS; Hinsch A
Sci Rep; 2023 Aug; 13(1):12917. PubMed ID: 37558687
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database.
Wu R; Luo J; Wan H; Zhang H; Yuan Y; Hu H; Feng J; Wen J; Wang Y; Li J; Liang Q; Gan F; Zhang G
PLoS One; 2023; 18(1):e0280340. PubMed ID: 36701415
[TBL] [Abstract] [Full Text] [Related]
5. Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study.
Omi Y; Haniu K; Kamio H; Fujimoto M; Yoshida Y; Horiuchi K; Okamoto T
World J Surg Oncol; 2022 Dec; 20(1):394. PubMed ID: 36510206
[TBL] [Abstract] [Full Text] [Related]
6. Incidence and mortality by cancer in the Pasto municipality, Colombia. 2013-2017.
Yépez Chamorro MC; Bravo Goyes LM; Jurado Fajardo D; Mena Huertas J; Casas HM
Colomb Med (Cali); 2022; 53(1):e2054952. PubMed ID: 36415600
[TBL] [Abstract] [Full Text] [Related]
7. The relationship between papillary thyroid cancer and triglyceride/glucose index, which is an indicator of insulin resistance.
Alkurt EG; Şahin F; Tutan B; Canal K; Turhan VB
Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6114-6120. PubMed ID: 36111913
[TBL] [Abstract] [Full Text] [Related]
8. Survivorship Care Plans Improve the Identification of Post-radiation Hypothyroidism After Head and Neck cancer Treatment.
Milas ZL; Neelands B; Trufan SJ; Benbow J; Carrizosa D; Brickman DS; Frenkel CH; Sumrall AL; Sudhakar SM; Ward MC
Anticancer Res; 2022 Sep; 42(9):4429-4437. PubMed ID: 36039459
[TBL] [Abstract] [Full Text] [Related]
9. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
Reiswich V; Könemann S; Lennartz M; Höflmayer D; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Kind S; Jacobsen F; Steurer S; Minner S; Büscheck F; Burandt E; Marx AH; Lebok P; Krech T
Pathol Res Pract; 2022 Sep; 237():154028. PubMed ID: 35872365
[TBL] [Abstract] [Full Text] [Related]
10. Inflammation Markers Have Important Value in Predicting Relapse in Patients with papillary thyroid carcinoma: A Long-Term Follow-Up Retrospective Study.
Huang Y; Liu Y; Mo G; Zhou T; Hou Q; Shi C; Jiang Q; Lv Y
Cancer Control; 2022; 29():10732748221115236. PubMed ID: 35833862
[TBL] [Abstract] [Full Text] [Related]
11. Weight-change trajectory in relation to cancer risk: findings from a nationwide cohort study in South Korea.
Tran TPT; Luu NM; Bui TT; Han M; Lim MK; Oh JK
Obesity (Silver Spring); 2022 Jul; 30(7):1507-1519. PubMed ID: 35785482
[TBL] [Abstract] [Full Text] [Related]
12. Trophoblast Cell Surface Antigen 2 Expression in Human Tumors: A Tissue Microarray Study on 18,563 Tumors.
Dum D; Taherpour N; Menz A; Höflmayer D; Völkel C; Hinsch A; Gorbokon N; Lennartz M; Hube-Magg C; Fraune C; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T; Luebke AM
Pathobiology; 2022; 89(4):245-258. PubMed ID: 35477165
[TBL] [Abstract] [Full Text] [Related]
13. Non-cancer disease prevalence and association with occupational radiation exposure among Korean radiation workers.
Park S; Lee DN; Jin YW; Cha ES; Jang WI; Park S; Seo S
Sci Rep; 2021 Nov; 11(1):22415. PubMed ID: 34789809
[TBL] [Abstract] [Full Text] [Related]
14. DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples.
Jansen K; Farahi N; Büscheck F; Lennartz M; Luebke AM; Burandt E; Menz A; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Lebok P; Sauter G; Simon R; Uhlig R; Wilczak W; Jacobsen F; Minner S; Krech R; Clauditz T; Bernreuther C; Dum D; Krech T; Marx A; Steurer S
Pathol Res Pract; 2021 Dec; 228():153663. PubMed ID: 34717148
[TBL] [Abstract] [Full Text] [Related]
15. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples.
Rico SD; Mahnken M; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Möller-Koop C; Fraune C; Möller K; Menz A; Bernreuther C; Jacobsen F; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Marx AH
Technol Cancer Res Treat; 2021; 20():15330338211043328. PubMed ID: 34547930
[No Abstract] [Full Text] [Related]
16. Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin.
Steurer S; Schneider J; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Menz A; Bernreuther C; Lebok P; Sauter G; Simon R; Jacobsen F; Uhlig R; Wilczak W; Minner S; Burandt E; Krech RH; Dum D; Krech T; Marx AH; Clauditz TS
Ann Diagn Pathol; 2021 Oct; 54():151793. PubMed ID: 34425503
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.
Menz A; Bauer R; Kluth M; Marie von Bargen C; Gorbokon N; Viehweger F; Lennartz M; Völkl C; Fraune C; Uhlig R; Hube-Magg C; De Wispelaere N; Minner S; Sauter G; Kind S; Simon R; Burandt E; Clauditz T; Lebok P; Jacobsen F; Steurer S; Wilczak W; Krech T; Marx AH; Bernreuther C
Hum Pathol; 2021 Sep; 115():19-36. PubMed ID: 34102222
[TBL] [Abstract] [Full Text] [Related]
18. Associations between essential microelements exposure and the aggressive clinicopathologic characteristics of papillary thyroid cancer.
Hu MJ; He JL; Tong XR; Yang WJ; Zhao HH; Li GA; Huang F
Biometals; 2021 Aug; 34(4):909-921. PubMed ID: 33961183
[TBL] [Abstract] [Full Text] [Related]
19. Standardization of thyroid ultrasound reporting in the community setting decreases biopsy rates.
Ghazizadeh S; Kelly TL; Khajanchee YS; Fleser J; Rozenfeld Y; Neuman M; Hammill CW; Orr L; Aliabadi-Wahle S
Clin Endocrinol (Oxf); 2021 Jun; 94(6):1035-1042. PubMed ID: 33529386
[TBL] [Abstract] [Full Text] [Related]
20. Endocrine Tumor Board: Ten Years' Experience of a Multidisciplinary Clinical Working Conference.
Savitz A; Fong B; Hochberg A; Rumore G; Chen C; Yun J; Sadur C
Perm J; 2020; 24():. PubMed ID: 32663125
[TBL] [Abstract] [Full Text] [Related]
[Next]
